[해외주식] CWBR CohBar 추적 완료! 구매 기회? / CWBR CohBar retracement completed !…
주식개미
0
1705
2021.08.18 09:12
CohBar, Inc
CryptoFundManager
CWBR CohBar is developing mitochondria based therapeutics for the treatment of age-related diseases.
So it`s an anti-aging listed companies.
They released positive topline results from an early stage study into CB4211, a drug under development for the treatment of nonalcoholic steatohepatitis, but after a 70% increase, the stock went even lower than before the pump.
WBB Securities upgraded CohBar , Inc. stock to Buy from Speculative Buy with a price target of $5.
On 4/23/2021 Maxim Group brokerage Initiated Coverage with a Buy rating and a price target of $3.00
The Market Cap is only 72.138M
I see a lot of potential in this stock! Do you?
So it`s an anti-aging listed companies.
They released positive topline results from an early stage study into CB4211, a drug under development for the treatment of nonalcoholic steatohepatitis, but after a 70% increase, the stock went even lower than before the pump.
WBB Securities upgraded CohBar , Inc. stock to Buy from Speculative Buy with a price target of $5.
On 4/23/2021 Maxim Group brokerage Initiated Coverage with a Buy rating and a price target of $3.00
The Market Cap is only 72.138M
I see a lot of potential in this stock! Do you?
번역:
코바
CryptoFundManager
CWBR CohBar는 미토콘드리아 기반의 노인성 질환 치료제를 개발하고 있다.
안티에이징 상장사네요.
비알코올성 지방간염 치료제인 CB4211에 대한 초기 연구 결과 양성을 보였으나 70% 증가 후 펌프 이전보다 주식이 더 떨어졌다.
WBB증권은 코바 주식회사를 투기매수에서 매수매수로 가격목표 5달러로 상향 조정했다.
2021년 4월 23일 Maxim Group 중개 개시 구매 등급 및 가격 목표 $3.00
시가총액은 721억 3800만 달러에 불과합니다.
이 주식에 잠재력이 많군요! 그러니?
원문링크: https://www.tradingview.com/chart/CWBR/EcB4TzVy-CWBR-CohBar-retracement-completed-Buy-opportunity/
[본문뒤 추가문구] 서학개미 투자포럼 - 해외투자 트렌드의 중심
